Results 201 to 210 of about 81,694 (308)

Monte Carlo simulation approach for health risk analysis of heavy metals' contamination in infant formula and food on the Iranian market. [PDF]

J Health Popul Nutr
Rahati S, Asadi Touranlou F, Afshari A, Hashemi M, Orooji A, Tavakoly Sany SB.   +5 more
europepmc   +1 more source

European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction‐associated steatotic liver disease

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common reason for elevated liver enzymes in children in Europe, affecting more than 5% of all children. Since the last iteration of this position paper, there have been substantial advances in our understanding of the disease.
Jake P. Mann, Sander Lefere, Maarten Buytaert, Anna Alisi, Cigdem Arikan, Jernej Brecelj, Rachel M. Brown, Irene Degrassi, Giulia Fiore, Emer Fitzpatrick, Sven Francque, Christian A. Hudert, Wojciech Janczyk, Lauren Johansen, Bart G. Koot, Anastasia Konidari, Eberhard Lurz, Claudia Mandato, Maria Mercadal‐Hally, Hadar Moran‐Lev, Antonella Mosca, Giusy Ranucci, Maria Rogalidou, Penelope C. Rose, Piotr Socha, Pietro Vajro, Elvira Verduci, Anita C. E. Vreugdenhil, Natalia Zavhorodnia, Aglaia Zellos, Ruth De Bruyne   +30 more
wiley   +1 more source

Emerging microbial risks: Cronobacter sakazakii in powdered infant formula for infants under six months of age in Ethiopia. [PDF]

BMC Microbiol
Sima WG, Legesse T, Girma S, Abera F, Yohanis T, Desta K, Tesema M.   +6 more
europepmc   +1 more source

Immunological effects of alpha-lactalbumin-enriched low-protein infant formula: A randomized controlled trial. [PDF]

J Pediatr Gastroenterol Nutr
Nilsson UT, Hernell O, Lönnerdal B, Jacobsen LN, Nunez-Salces M, Kvistgaard AS, West C, Åkeson PK.   +7 more
europepmc   +1 more source

Glutamine and partially hydrolyzed guar gum promote intestinal adaptation and modulate small intestinal microbiota in high‐output stoma: A case report

JPGN Reports, EarlyView.
Abstract We report a case of a very low‐birth‐weight infant with a high‐output stoma following necrotizing enterocolitis. The patient exhibited villous atrophy and microbial dysbiosis. Supplementation with glutamine and partially hydrolyzed guar gum (PHGG) was initiated, leading to reduced stoma output, improved feeding tolerance, and appropriate ...
Yunosuke Kawaguchi, Keita Terui, Ayako Takenouchi, Shugo Komatsu, Ryohei Shibata, Katsuhiro Nishimura, Shota Takiguchi, Yukiko Iwase, Rei Hashimoto, Keisuke Matsusaka, Yoshiteru Osone, Jun‐ichiro Ikeda, Tomoro Hishiki   +12 more
wiley   +1 more source

Socioeconomic status and psychosocial or contextual factors related to the use of infant formula and follow-up milk: a survey among Japanese mothers. [PDF]

BMC Nutr
Endoh K.
europepmc   +1 more source

Coping Practices of Small‐ and Medium‐Sized Enterprises Facing Power Asymmetry in Digital Platform Business

Strategic Change, EarlyView.
ABSTRACT Digital platform (DP) enterprises have risen to the top of the global economy by inverting traditional business models. They earn money through matchmaking, transaction facilitation, and efficient orchestration of other stakeholders' resources.
Lukas R. G. Fitz, Jochen Scheeg
wiley   +1 more source

Transcriptomic comparison of human intestinal organoids and Caco-2 cells in modeling nutrient absorption: insights from infant formula and breast milk. [PDF]

NPJ Sci Food
Wang X, Zhang W, Yang S, Zheng C, Wang Z, Yang G, Huang C, Yao H, Huang K, Yan Y, Jiang S, Sun J, Xie Q, Zhang Y, Li X, Wang H.   +15 more
europepmc   +1 more source

The Path to Lean Startup Risk Management

Strategic Change, EarlyView.
ABSTRACT This paper aims to demonstrate that many startups are unaware of the potential of strategic opportunity and risk management to gain a competitive advantage. It reveals and analyzes an opportunity and risk management gap between the pre‐startup and early‐startup phases, guiding toward managerial implications.
Maximilian Wagenknecht
wiley   +1 more source